Oil rises due to firm yuan, expectations of more OPEC cuts
Oil jumped more than $1 a barrel on Thursday due to expectations that falling prices may lead to production cuts, coupled with a steadying of...
Markets find a floor as Chinese data soothe nerves
Stock markets enjoyed a tentative recovery on Thursday after better-than-expected Chinese export data, while a steadying of the yuan restored some calm to global markets...
Christchurch victims and families seek healing at haj
After surviving the shootings at Christchurch that killed 51 people and injured dozens in March, victims and their families searched for peace and relief at...
Short-term spike in radiation in city registered after rocket engine explosion: TASS
A short-term spike in radiation levels in Severodvinsk was recorded after an explosion on a rocket engine at a military testing site on Thursday, TASS...
Poland’s parliament speaker resigns amid private flights scandal
Poland’s parliament speaker, Marek Kuchcinski, said on Thursday he would resign after it was revealed that he used government aircraft for private trips by family...
China data, steadying yuan lift futures
U.S. stock index futures inched higher on Thursday as better-than-expected Chinese trade data and a steadying of its currency offered some comfort to investors rattled...
Viacom beats quarterly revenue, profit estimates as ad revenue rebounds
Viacom Inc , the owner of MTV, Comedy Central and Nickelodeon, beat estimates for quarterly revenue and profit on Thursday, as it posted rare growth...
Study shows Apple devices in combo with apps could identify dementia
Drugmaker Eli Lilly said initial results from a study suggest that Apple Inc devices, including the iPhone, in combination with digital apps could differentiate people...
Viacom beats quarterly revenue estimates
Viacom Inc , the owner of MTV, Comedy Central and Nickelodeon, beat estimates for quarterly revenue on Thursday, helped by a rare growth in domestic...
Bayer buys BlueRock in $600 million bet on stem cell therapies
German drugmaker Bayer is paying up to $600 million for full control of cell therapy developer BlueRock Therapeutics, stepping up investment in a promising new...